Tungsten Alloy Syringe Shielding Sleeves

Tungsten Alloy Syringe Shielding Sleeves Picture

1. What Are Tungsten Alloy Syringe Shielding Sleeves?
Tungsten alloy syringe shielding sleeves, also known as tungsten alloy syringe shields, are radiation protection components fitted around syringes to attenuate X-rays and γ-rays during radiopharmaceutical extraction, preparation, and injection in nuclear medicine, protecting the hands, fingers, and forearms of healthcare personnel. CTIA’s tungsten alloy syringe shielding sleeves offer efficient radiation shielding, compact structures, high mechanical strength, and lead-free protection, providing a smaller and lighter alternative to lead sleeves under equivalent shielding requirements for nuclear medicine, Positron Emission Tomography (PET), and radiopharmaceutical handling.

2. Features of CTIA’s Tungsten Alloy Syringe Shielding Sleeves
(1) High Density, Strong Shielding: Density of 17.0–18.5 g/cm³, more than 1.5 times that of lead at 11.34 g/cm³, provides effective attenuation of X-rays and γ-rays. Compact structures and lower weight facilitate hand-held operation under equivalent shielding requirements.
(2) Small Size, Low Weight: Wall thickness of 2–9 mm and optimized structural design reduce overall weight while maintaining shielding performance, making prolonged hand-held operation easier.
(3) Flexible Size Matching: Supports 1 cc, 2 cc, 3 cc, 5 cc, and 10 cc syringes, with internal openings customizable to different syringe dimensions for accurate fitting.
(4) Clear Viewing: Long viewing slots or integrated lead glass windows on selected models allow observation of syringe graduations, medication status, and injection procedures.
(5) Lead-Free, Durable: Lead-free tungsten alloy provides good mechanical strength, corrosion resistance, and impact resistance for repeated use and routine cleaning.

3. Applications of CTIA’s Tungsten Alloy Syringe Shielding Sleeves
(1) Nuclear Medicine Drug Handling: Protecting against radiation during the extraction, dispensing, and injection of radiopharmaceuticals such as technetium-99m (Tc-99m) and fluorine-18 (F-18).
(2) PET Imaging: Shielding healthcare personnel during radiopharmaceutical injection, including procedures involving positron-emitting radionuclides such as fluorine-18 (F-18) and carbon-11 (C-11).
(3) Radiopharmaceutical Preparation: Shielding syringes during automated dispensing and manual preparation to reduce occupational radiation exposure.
(4) Research Experiments: Providing localized radiation protection during injection procedures in radioactive isotope tracing experiments and nuclear technology research.

4. Specifications of CTIA’s Tungsten Alloy Syringe Shielding Sleeves
(1) Material: W-Ni-Fe, W-Ni-Cu
(2) Density: 17.0–18.5 g/cm³
(3) Syringe Compatibility: 1 mL, 2 mL, 2.5 mL, 3 mL, 5 mL, 10 mL, customizable
(4) Dimensions: customizable

CTIA GROUP has nearly 30 years of experience in tungsten alloy manufacturing, specializing in precision processing of tungsten alloy shielding components. CTIA provides tungsten alloy syringe shielding sleeves in various densities, dimensions, and structural configurations, tailored to syringe specifications, radionuclide types, shielding requirements, and operating conditions for nuclear medicine, radiopharmaceutical preparation, and research applications.

For any inquiry, please contact tungsten alloy manufacturer: CTIA GROUP

Email: sales@chinatungsten.com

Tel: 0086 592 5129696 / 0086 592 5129595

Website: tungsten-alloy.com

WeChat:

Business Wechat of CTIA GROUP